Binding Ability Studies of Arginine, Citrulline, N-Acetyl Citrulline and Thiocitrulline with SARS Cov-2 Main Protease Using Molecular Docking Studies
To Editor in Chief Chemarxiv Respected Sir/Madam Subject: submission of preprint of an article to ChemRxiv on molecular docking studies of arginine and its structural analogues on COV-19 for publication. I am herewith submitting the preprint of an article entitled “Binding ability studies of arginin...
Saved in:
Published in | ChemRxiv |
---|---|
Main Author | |
Format | Paper |
Language | English |
Edition | 1 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To
Editor
in Chief
Chemarxiv
Respected
Sir/Madam
Subject: submission of preprint of an article to ChemRxiv on molecular
docking studies of arginine and its structural analogues on COV-19 for
publication.
I
am herewith submitting the preprint of an article entitled “Binding ability studies of arginine,
citrulline, N-acetyl citrulline and thiocitrulline with SARS Cov-2 main
protease using molecular docking studies.” for publication as preprint in “ChemRxiv”.
In
this paper the binding abilities of arginine, citrulline, N-acetyl citrulline
and thiocitrulline with SARS-COV-2 protease have been examined using molecular
docking studies. The ligands used for docking has moderate binding affinity to
active sites of main protease in terms of values. The binding affinities of these ligands are in
the range of -3.1 to -5.1 kcal mol-1.
All the ligands bind selectively to Cys-145 and also to other amino acids
surrounding to it in the main protease. Of which arginine forms less number of
weaker bonds compared to the other ligands, it by itself is a precursor for the
formation of citrulline analogues with in the cell. Major advantage of using
the above ligands is that in addition to its preferential binding these
molecules also have the ability to enhance the immunity of the cells by the
generation of nitric oxide in presence of enzymes thereby protecting them. Our
results show that N-acetyl citrulline, citrulline, thiocitrulline and arginine
may be used as a supplement during the treatment of SARS-COV-2.
I request your good self to kindly accept the
article and get it published as pre-print in your esteemed ChemRxiv.
Thanking you
With regards
Ramesh T N
(adityaramesh77@yahoo.com) |
---|---|
Bibliography: | No conflict of interest |
ISSN: | 2573-2293 |
DOI: | 10.26434/chemrxiv.12196833.v1 |